Free Republic

Moderna stock spiked in Wednesday trading, climbing 13.7% over the course of the day amid swelling concerns over the avian influenza outbreak in U.S. cattle...Moderna confirmed to Barron's that the company is in discussions with the federal government about "advancing our pandemic flu candidate." Pfizer did not immediately respond to a request for comment.

The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a COVID-19 vaccine that has earned it at least $400 million.The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.She cited an exemption outlined in the act that allows government agencies to partially or fully withhold information.“In this case, exemption 3 incorporates 35 U.S.C. 209 (f),...

Pfizer is investing billions of dollars in treatments to prepare for a looming “heart failure pandemic.”The Covid mRNA vaccine maker is making a big investment in treatment for heart failure as cases of myocarditis and sudden cardiac deaths skyrocket.The pharmaceutical giant recently acquired several companies.This includes a major $6.7 billion cash acquisition of Arena Pharmaceuticals.Arena Pharmaceuticals is a firm specializing in developing treatments, particularly for heart inflammation conditions like myocarditis and pericarditis.Pfizer is now predicted to make tens of billions of dollars in profits from the spike in heart failure.The company is expecting to capitalize on the huge spike in...